Abstract
1. In this minireview we address the predictive value of blood pressure variability, over and beyond level of pressure, in randomly selected population samples. All reviewed studies had sufficient power, long follow-up duration and a wide age range. 2. We assessed blood pressure variability derived from home visit, self-measured home pressure and 24 h ambulatory monitoring. The conclusions are based mainly on novel indices of blood pressure variability: variability independent of the mean, difference between maximum and minimum blood pressure and average real variability. 3. None of these variability indices or morning surge in blood pressure substantially refined risk profiling over and beyond the blood pressure level. 4. In risk stratification, clinicians should concentrate on blood pressure level, the predominant risk factor modifiable by lifestyle measures and antihypertensive drug treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Clinical and Experimental Pharmacology and Physiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.